Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

CTNM — Contineum Therapeutics, Inc. Dilution Risk Tracker

Track CTNM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CTNM — Get alerts when the score changes →

As of October 13, 2026, Contineum Therapeutics, Inc. (CTNM) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Contineum Therapeutics, Inc. has a market capitalization of $197.84M, 23.10M shares outstanding, 91 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $100M remaining capacity
🔔 Track CTNM — Get forecast alerts →

Market Data

Market Cap$197.84M
Shares Outstanding23.10M
FloatN/A
Cash$236.55M
Debt$6.95M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore32/100DilutionWatch score record
Shares Outstanding23.10MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$197.84MMarket data cache
Cash Runway64.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 3, 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 35.1% shares (2026Q1 vs prior)
91 institutional holders · 40.40M shares
#1 JOHNSON & JOHNSON 5.94M shares
#2 JANUS HENDERSON GROUP PLC 5.47M shares
#3 SUVRETTA CAPITAL MANAGEMENT, LLC 2.84M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.07M
Days to Cover3.6
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-05
xbrl XBRL CONVERTIBLE 2026-03-05
424B5 ATM 2026-03-05
8-K 8K EVENT 2026-03-05
4 INSIDER TRANSACTION 2026-03-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CTNM Dilution Snapshot

Contineum Therapeutics, Inc. (CTNM) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CTNM's DilutionScore has held steady at 32/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202632/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CTNM shares outstanding have increased 7.5% from 30.45M (Mar 2026) to 32.72M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202632.72M27.59M▲ 8.64%
May 08, 202632.72M25.40M▲ 0.13%
May 03, 202632.67M25.36M▲ 0.02%
Apr 10, 202632.67M25.36M▲ 0.02%
Mar 12, 202630.45M25.36M▲ 5.96%
Mar 11, 202630.45M23.93M▲ 40.72%
Mar 05, 202630.45M17.00M▲ 0.02%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CTNM Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CTNM files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CTNM — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for CTNM
CTNM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.